Product Information

OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Alvogen Inc., priced at $0.1511 per ML under NDC 47781038426. Its NADAC has been published 449 times since Jan 17, 2018.

FDA first approved this application on Oct 31, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR 6 MG/ML SUSPENSION

Oseltamivir Phosphate
$0.1511per ML

Strength

6 mg/mL

Manufacturer

Alvogen Inc.

NDC

47781038426

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208823

FDA Approved

10/31/2017

TE Code

AB

On Market Since

11/1/2017

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 449 times since Jan 17, 2018, and over the history we have for it it has declined 90.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1511 per ML
All-time high$1.5535 (Feb 14, 2018)
All-time low$0.1271 (Nov 20, 2024)
52-week high$0.1739
52-week low$0.1497
Median price$0.3998
Average price$0.5515
Largest weekly change-56.9% (Sep 20, 2023)
Weeks tracked449
Tracking sinceJan 17, 2018

Price History

1W

-1.3%

1M

-1.3%

3M

-4.0%

6M

-0.5%

1Y

-11.1%

3Y

-64.8%

5Y

-60.1%

All

-90.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Alvogen Inc., is $0.1511 per ML (NDC 47781038426), effective Aug 19, 2026.

How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 90.3%. It has been tracked across 449 weekly CMS publications since Jan 17, 2018.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?

Since Jan 17, 2018, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $1.5535 (Feb 14, 2018), with a median of $0.3998 per ML.

Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.

Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?

OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 47781038426) is labeled by Alvogen Inc., and CMS classifies it as a generic product.